LV11177A - Jauns farmaceitisks produkts - Google Patents

Jauns farmaceitisks produkts

Info

Publication number: LV11177A
Authority: LV; Latvia
Prior art keywords: pharmaceutical product; new pharmaceutical; new; product; pharmaceutical
Prior art date: 1994-09-19

Application number

LV950284A

Other languages

English (en)

Other versions

LV11177B (en

Inventor

Elizabeth S Labell

Wayne D Luke

John Mc Mcgill

Randal S Miller

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-09-19

Filing date

1995-09-18

Publication date

1996-04-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26976194&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LV11177(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1994-09-19 Priority claimed from US08/308,325 external-priority patent/US5629425A/en

1995-09-18 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

1996-04-20 Publication of LV11177A publication Critical patent/LV11177A/lv

1996-08-20 Publication of LV11177B publication Critical patent/LV11177B/en

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/56—Radicals substituted by oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

LVP-95-284A 1994-09-19 1995-09-18 Novel pharmaceutical product LV11177B (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/308,325 US5629425A (en)	1994-09-19	1994-09-19	Haloalkyl hemisolvates of 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-piperidinoethoxy)-benzoyl]benzo[b]thiophene
US42791495A	1995-04-26	1995-04-26

Publications (2)

Publication Number	Publication Date
LV11177A true LV11177A (lv)	1996-04-20
LV11177B LV11177B (en)	1996-08-20

Family

ID=26976194

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
LVP-95-285A LV11178B (en)	1994-09-19	1995-09-18	Synthesis of 3-£4-(2-aminoethoxy) benzoyl\|-2-aryl-6-hydroxybenzo £b\| thiophenes
LVP-95-284A LV11177B (en)	1994-09-19	1995-09-18	Novel pharmaceutical product

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
LVP-95-285A LV11178B (en)	1994-09-19	1995-09-18	Synthesis of 3-£4-(2-aminoethoxy) benzoyl\|-2-aryl-6-hydroxybenzo £b\| thiophenes

Country Status (51)

Country	Link
US (4)	US6399778B1 (lv)
JP (2)	JPH08193081A (lv)
KR (2)	KR100367376B1 (lv)
CN (2)	CN1068324C (lv)
AP (1)	AP754A (lv)
AT (2)	AT407988B (lv)
AU (3)	AU691955B2 (lv)
BE (2)	BE1009626A3 (lv)
BG (1)	BG62793B1 (lv)
BR (2)	BR9504060A (lv)
CA (2)	CA2158399C (lv)
CH (3)	CH691594A5 (lv)
CO (2)	CO4410191A1 (lv)
CZ (2)	CZ290343B6 (lv)
DE (3)	DE19534744A1 (lv)
DK (4)	DK175897B1 (lv)
EE (1)	EE03386B1 (lv)
EG (1)	EG23763A (lv)
ES (2)	ES2109882B1 (lv)
FI (2)	FI112226B (lv)
FR (2)	FR2724655B1 (lv)
GB (2)	GB2293602B (lv)
GE (1)	GEP19991821B (lv)
GR (2)	GR1002697B (lv)
HK (1)	HK1019009A1 (lv)
HR (2)	HRP950483B1 (lv)
HU (2)	HU225417B1 (lv)
IE (2)	IE80883B1 (lv)
IL (3)	IL125283A (lv)
IS (1)	IS1788B (lv)
IT (2)	IT1277602B1 (lv)
LU (2)	LU88661A1 (lv)
LV (2)	LV11178B (lv)
MY (1)	MY116371A (lv)
NL (2)	NL1001196C2 (lv)
NO (2)	NO308107B1 (lv)
NZ (2)	NZ280027A (lv)
OA (1)	OA10406A (lv)
PE (2)	PE32796A1 (lv)
PL (2)	PL187686B1 (lv)
PT (2)	PT101771B (lv)
RO (2)	RO115260B1 (lv)
RS (2)	RS49513B (lv)
SE (2)	SE520721C2 (lv)
SI (2)	SI9500293A (lv)
SK (1)	SK283502B6 (lv)
TR (1)	TR199501136A2 (lv)
TW (1)	TW412534B (lv)
UA (2)	UA42716C2 (lv)
UY (1)	UY24040A1 (lv)
WO (1)	WO1996009045A1 (lv)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
USRE39049E1 (en)	1992-07-28	2006-03-28	Eli Lilly And Company	Methods for inhibiting bone loss
TW366342B (en) *	1992-07-28	1999-08-11	Lilly Co Eli	The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
USRE38968E1 (en)	1992-07-28	2006-02-07	Eli Lilly And Company	Methods for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl-4-[2-(piperidin-1-yl) ethoxyphenylimethanone hydrochloride
US5478847A (en)	1994-03-02	1995-12-26	Eli Lilly And Company	Methods of use for inhibiting bone loss and lowering serum cholesterol
CO4410191A1 (es) *	1994-09-19	1997-01-09	Lilly Co Eli	SINTESIS DE 3-[4-(2-AMINOETOXI)BENZOIL]-2-ARIL-6- HIDROXIBENZO [b] TIOFENOS
US6458811B1 (en) *	1996-03-26	2002-10-01	Eli Lilly And Company	Benzothiophenes formulations containing same and methods
TR199801915T2 (xx)	1996-03-26	1998-12-21	Eli Lilly And Company	Benzotiofenler, bunlar� ihtiva eden form�lasyonlar ve y�ntemler.
ZA979720B (en)	1996-10-30	1999-04-29	Lilly Co Eli	Prophylaxis of breast cancer
CA2236254A1 (en) *	1997-04-30	1998-10-30	David Warren Hoard	Process for preparing benzo¬b\|thiophenes
WO2000066612A1 (en)	1999-05-04	2000-11-09	Strakan Limited	Androgen glycosides and androgenic activity thereof
US6921827B2 (en) *	2000-11-27	2005-07-26	Eli Lilly And Company	Process for preparing 3-aryl-benzo{b} thiophenes
JP4625637B2 (ja)	2002-02-22	2011-02-02	シャイアエルエルシー	活性物質送達系及び活性物質を保護し投与する方法
US7407955B2 (en)	2002-08-21	2008-08-05	Boehringer Ingelheim Pharma Gmbh & Co., Kg	8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
EP1826205A1 (en)	2002-09-30	2007-08-29	A/S GEA Farmaceutisk Fabrik	Novel raloxifene succinic acid addition salts and/or solvates thereof, and pharmaceutical compositions comprising these
US6861422B2 (en)	2003-02-26	2005-03-01	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
US20060106010A1 (en) *	2003-05-27	2006-05-18	Black Larry J	Methods for inhibiting bone loss
US7501426B2 (en)	2004-02-18	2009-03-10	Boehringer Ingelheim International Gmbh	8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004029784A1 (de)	2004-06-21	2006-01-05	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
DE102004030502A1 (de)	2004-06-24	2006-01-12	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Imidazole und Triazole, deren Herstellung und Verwendung als Arzneimittel
DE102004033670A1 (de)	2004-07-09	2006-02-02	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
US20060058311A1 (en)	2004-08-14	2006-03-16	Boehringer Ingelheim International Gmbh	Combinations for the treatment of diseases involving cell proliferation
US20060074088A1 (en)	2004-08-14	2006-04-06	Boehringer Ingelheim International Gmbh	Dihydropteridinones for the treatment of cancer diseases
US20060035903A1 (en)	2004-08-14	2006-02-16	Boehringer Ingelheim International Gmbh	Storage stable perfusion solution for dihydropteridinones
US7728134B2 (en)	2004-08-14	2010-06-01	Boehringer Ingelheim International Gmbh	Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
US7759485B2 (en)	2004-08-14	2010-07-20	Boehringer Ingelheim International Gmbh	Process for the manufacture of dihydropteridinones
EP1630163A1 (de)	2004-08-25	2006-03-01	Boehringer Ingelheim Pharma GmbH & Co.KG	Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
AU2005289100B2 (en)	2004-09-29	2011-11-03	Bayer Healthcare Llc	Thermodynamically stable form of bay 43-9006 tosylate
US20060068010A1 (en) *	2004-09-30	2006-03-30	Stephen Turner	Method for improving the bioavailability of orally delivered therapeutics
DE102004054054A1 (de)	2004-11-05	2006-05-11	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102004058337A1 (de)	2004-12-02	2006-06-14	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten
DE102005035891A1 (de)	2005-07-30	2007-02-08	Boehringer Ingelheim Pharma Gmbh & Co. Kg	8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
US7439358B2 (en)	2006-02-08	2008-10-21	Boehringer Ingelheim International Gmbh	Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
PE20110235A1 (es)	2006-05-04	2011-04-14	Boehringer Ingelheim Int	Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
EP1852108A1 (en)	2006-05-04	2007-11-07	Boehringer Ingelheim Pharma GmbH & Co.KG	DPP IV inhibitor formulations
CN101437823B (zh)	2006-05-04	2014-12-10	勃林格殷格翰国际有限公司	多晶型
AR062927A1 (es)	2006-10-11	2008-12-17	Bayer Healthcare Ag	4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
WO2008047105A1 (en) *	2006-10-17	2008-04-24	Cipla Limited	Crystalline form of benzothiophene compound and process for preparation thereof
US20080103295A1 (en) *	2006-10-25	2008-05-01	David Losan Ho	Process for the preparation of sucrose-6-ester by esterification in the presence of solid superacid catalyst
US8258291B2 (en) *	2006-10-25	2012-09-04	Mamtek International Limited	Process for the preparation of sucralose by the chlorination of sugar with triphosgene (BTC)
DE102007032451B4 (de)	2007-07-12	2010-09-30	Icfs Gmbh	Verfahren zur Herstellung von aromatischen Ketonen
WO2009015004A1 (en) *	2007-07-20	2009-01-29	King Pharmaceuticals Research And Development, Inc.	Crystals of (2-amino-4,5,6,7-tetrahydrobenzo[b]thien-3-yl)(4-chlorophenyl)methanone
EP3098223A1 (en)	2007-08-03	2016-11-30	Boehringer Ingelheim International GmbH	Crystalline form of a dihydropteridione derivative
EP2242483B1 (en) *	2007-12-21	2013-02-20	Synthon B.V.	Raloxifene composition
AR071175A1 (es)	2008-04-03	2010-06-02	Boehringer Ingelheim Int	Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante
US20110088613A1 (en) *	2008-06-09	2011-04-21	Massimo Ferrari	Process for controlling the growth of a raloxifene hydrochloride crystal
UY32030A (es)	2008-08-06	2010-03-26	Boehringer Ingelheim Int	"tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
BRPI0916997A2 (pt)	2008-08-06	2020-12-15	Boehringer Ingelheim International Gmbh	Inibidor de dpp-4 e seu uso
EP2344195A2 (en)	2008-09-10	2011-07-20	Boehringer Ingelheim International GmbH	Combination therapy for the treatment of diabetes and related conditions
US20200155558A1 (en)	2018-11-20	2020-05-21	Boehringer Ingelheim International Gmbh	Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
NZ592924A (en)	2008-12-23	2014-05-30	Boehringer Ingelheim Int	Salt forms of a xanthine derivative
AR074990A1 (es)	2009-01-07	2011-03-02	Boehringer Ingelheim Int	Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
WO2011000581A2 (en)	2009-07-02	2011-01-06	Synthon B.V.	Raloxifene composition
EP2314581B1 (en)	2009-10-23	2012-07-25	Hexal AG	A process for preparing benzo[b]thiophene derivatives
BR112012012641A2 (pt)	2009-11-27	2020-08-11	Boehringer Ingelheim International Gmbh	TRATAMENTO DE PACIENTES DIABÉTICOS GENOTIPADOS COM INIBIDORES DE DPP-lVTAL COMO LINAGLIPTINA
WO2011099942A1 (en)	2010-02-09	2011-08-18	Silverstone Pharma	New addition salts of raloxifene, process for the preparation thereof and use thereof in therapy
MX341025B (es)	2010-05-05	2016-08-04	Boehringer Ingelheim Int Gmbh *	Terapia de combinacion.
ES2802243T3 (es)	2010-06-24	2021-01-18	Boehringer Ingelheim Int	Terapia para la diabetes
US8546566B2 (en)	2010-10-12	2013-10-01	Boehringer Ingelheim International Gmbh	Process for manufacturing dihydropteridinones and intermediates thereof
IT1403083B1 (it) *	2010-10-25	2013-10-04	Fidia Farmaceutici	Nuova forma polimorfa di raloxifene cloridrato
AR083878A1 (es)	2010-11-15	2013-03-27	Boehringer Ingelheim Int	Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
US9358233B2 (en)	2010-11-29	2016-06-07	Boehringer Ingelheim International Gmbh	Method for treating acute myeloid leukemia
US9370535B2 (en)	2011-05-17	2016-06-21	Boehringer Ingelheim International Gmbh	Method for treatment of advanced solid tumors
EP3517539B1 (en)	2011-07-15	2022-12-14	Boehringer Ingelheim International GmbH	Substituted dimeric quinazoline derivative, its preparation and its use in pharmaceutical compositions for the treatment of type i and ii diabetes
US9555001B2 (en)	2012-03-07	2017-01-31	Boehringer Ingelheim International Gmbh	Pharmaceutical composition and uses thereof
WO2013171167A1 (en)	2012-05-14	2013-11-21	Boehringer Ingelheim International Gmbh	A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
WO2013174767A1 (en)	2012-05-24	2013-11-28	Boehringer Ingelheim International Gmbh	A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
ZA201401636B (en)	2013-03-05	2014-11-26	Cipla Ltd	Oxalic acid addition salts and/or solvates of a selective estrogen receptor modulator
EP3024464A1 (en)	2013-07-26	2016-06-01	Boehringer Ingelheim International GmbH	Treatment of myelodysplastic syndrome
WO2015128453A1 (en)	2014-02-28	2015-09-03	Boehringer Ingelheim International Gmbh	Medical use of a dpp-4 inhibitor
US9867831B2 (en)	2014-10-01	2018-01-16	Boehringer Ingelheim International Gmbh	Combination treatment of acute myeloid leukemia and myelodysplastic syndrome
CN104496963A (zh) *	2014-12-02	2015-04-08	千辉药业（安徽）有限责任公司	一种盐酸雷洛昔芬的制备方法
AU2017276758A1 (en)	2016-06-10	2018-11-08	Boehringer Ingelheim International Gmbh	Combinations of Linagliptin and metformin

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3869485A (en) *	1969-09-25	1975-03-04	Allied Chem	Preparation of acid chlorides with phosgene in the presence of a catalyst
GB1456323A (en) *	1974-06-06	1976-11-24	Labaz	Benzothiophenes process for preparing them and pharmaceutical compositions containing the same
US4133814A (en) *	1975-10-28	1979-01-09	Eli Lilly And Company	2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4380635A (en)	1981-04-03	1983-04-19	Eli Lilly And Company	Synthesis of acylated benzothiophenes
IL65379A0 (en)	1981-04-03	1982-05-31	Lilly Co Eli	Process for preparing acylated benzothiophenes
US4418068A (en)	1981-04-03	1983-11-29	Eli Lilly And Company	Antiestrogenic and antiandrugenic benzothiophenes
PH18628A (en)	1981-04-03	1985-08-23	Lilly Co Eli	"6-hydroxy-2-(4-hydroxyphenyl)-3 4-(2- piperidine or 3-methylpyrollidine -benzo b thiophene compounds
US4358593A (en)	1981-04-03	1982-11-09	Eli Lilly And Company	Process for preparing 3-(4-aminoethoxybenzoyl)benzo[b]thiophenes
IL65378A (en) *	1981-04-03	1986-02-28	Lilly Co Eli	Process for preparing 3-(4-aminoethoxybenzoyl)benzo-(b)thiophenes
ZA822247B (en)	1981-04-03	1983-11-30	Lilly Co Eli	Benzothiophene compounds and process for preparing them
DE4117512A1 (de) *	1991-05-25	1992-11-26	Schering Ag	2-phenylbenzo(b)furane und -thiophene, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
JP3157882B2 (ja) *	1991-11-15	2001-04-16	帝国臓器製薬株式会社	新規なベンゾチオフエン誘導体
US5169860A (en)	1992-03-13	1992-12-08	Eli Lilly And Company	Antitumor compositions and methods of treatment
TW383306B (en)	1992-12-22	2000-03-01	Lilly Co Eli	New use of 2-phenyl-3-aroylbenzothiophenes in lowering serum cholesterol
ZA944377B (en)	1993-06-24	1995-12-20	Lilly Co Eli	Hypoglycemic agents
US6756388B1 (en)	1993-10-12	2004-06-29	Pfizer Inc.	Benzothiophenes and related compounds as estrogen agonists
US5523416A (en)	1994-07-22	1996-06-04	Eli Lilly And Company	Process for preparing 3-(4-aminoethoxy-benzoyl) benzo (B)-thiophenes
CO4410191A1 (es) *	1994-09-19	1997-01-09	Lilly Co Eli	SINTESIS DE 3-[4-(2-AMINOETOXI)BENZOIL]-2-ARIL-6- HIDROXIBENZO [b] TIOFENOS

1995
- 1995-06-02 CO CO95023870A patent/CO4410191A1/es unknown
- 1995-06-02 CO CO95023869A patent/CO4410190A1/es unknown
- 1995-06-05 TW TW084105613A patent/TW412534B/zh not_active IP Right Cessation
- 1995-06-06 US US08/469,093 patent/US6399778B1/en not_active Expired - Fee Related
- 1995-06-06 US US08/469,961 patent/US6472531B1/en not_active Expired - Lifetime
- 1995-06-06 US US08/467,485 patent/US5731327A/en not_active Expired - Lifetime
- 1995-06-07 PE PE1995270673A patent/PE32796A1/es not_active IP Right Cessation
- 1995-06-07 PE PE1995270674A patent/PE14796A1/es not_active Application Discontinuation
- 1995-09-13 ES ES09501774A patent/ES2109882B1/es not_active Revoked
- 1995-09-13 ES ES009501775A patent/ES2129293B1/es not_active Expired - Fee Related
- 1995-09-14 NL NL1001196A patent/NL1001196C2/nl active Search and Examination
- 1995-09-14 IL IL12528395A patent/IL125283A/en not_active IP Right Cessation
- 1995-09-14 IL IL11531595A patent/IL115315A/xx not_active IP Right Cessation
- 1995-09-14 UA UA95094169A patent/UA42716C2/uk unknown
- 1995-09-14 NL NL1001194A patent/NL1001194C2/nl active Search and Examination
- 1995-09-14 UA UA95094168A patent/UA44240C2/uk unknown
- 1995-09-14 IL IL11531495A patent/IL115314A/xx not_active IP Right Cessation
- 1995-09-15 NZ NZ280027A patent/NZ280027A/en not_active IP Right Cessation
- 1995-09-15 KR KR1019950030209A patent/KR100367376B1/ko active IP Right Grant
- 1995-09-15 PT PT101771A patent/PT101771B/pt not_active IP Right Cessation
- 1995-09-15 CA CA002158399A patent/CA2158399C/en not_active Expired - Lifetime
- 1995-09-15 UY UY24040A patent/UY24040A1/es not_active IP Right Cessation
- 1995-09-15 NZ NZ280028A patent/NZ280028A/en not_active IP Right Cessation
- 1995-09-15 NO NO953657A patent/NO308107B1/no not_active IP Right Cessation
- 1995-09-15 NO NO19953658A patent/NO313996B1/no not_active IP Right Cessation
- 1995-09-15 SE SE9503213A patent/SE520721C2/sv not_active IP Right Cessation
- 1995-09-15 CZ CZ19952403A patent/CZ290343B6/cs not_active IP Right Cessation
- 1995-09-15 CA CA002158400A patent/CA2158400C/en not_active Expired - Lifetime
- 1995-09-15 RO RO95-01620A patent/RO115260B1/ro unknown
- 1995-09-15 PT PT101770A patent/PT101770B/pt not_active IP Right Cessation
- 1995-09-15 KR KR1019950030210A patent/KR100381346B1/ko active IP Right Grant
- 1995-09-15 IT IT95MI001936A patent/IT1277602B1/it active IP Right Grant
- 1995-09-15 IT IT95MI001935A patent/IT1277601B1/it active IP Right Grant
- 1995-09-15 SE SE9503214A patent/SE509265C2/sv not_active IP Right Cessation
- 1995-09-15 RO RO95-01619A patent/RO115259B1/ro unknown
- 1995-09-15 DK DK199501028A patent/DK175897B1/da not_active IP Right Cessation
- 1995-09-15 CZ CZ19952402A patent/CZ292007B6/cs not_active IP Right Cessation
- 1995-09-15 DK DK199501027A patent/DK175903B1/da not_active IP Right Cessation
- 1995-09-17 EG EG76395A patent/EG23763A/xx active
- 1995-09-18 CH CH01780/00A patent/CH691594A5/de not_active IP Right Cessation
- 1995-09-18 LU LU88661A patent/LU88661A1/fr unknown
- 1995-09-18 SI SI9500293A patent/SI9500293A/sl not_active IP Right Cessation
- 1995-09-18 AU AU31730/95A patent/AU691955B2/en not_active Expired
- 1995-09-18 JP JP7238209A patent/JPH08193081A/ja active Pending
- 1995-09-18 HU HU9502721A patent/HU225417B1/hu not_active IP Right Cessation
- 1995-09-18 LV LVP-95-285A patent/LV11178B/en unknown
- 1995-09-18 CN CN95118449A patent/CN1068324C/zh not_active Expired - Lifetime
- 1995-09-18 FI FI954402A patent/FI112226B/fi not_active IP Right Cessation
- 1995-09-18 SI SI9500292A patent/SI9500292A/sl not_active IP Right Cessation
- 1995-09-18 BE BE9500761A patent/BE1009626A3/fr active
- 1995-09-18 CH CH02628/95A patent/CH691478A5/de not_active IP Right Cessation
- 1995-09-18 GR GR950100340A patent/GR1002697B/el not_active IP Right Cessation
- 1995-09-18 GB GB9519032A patent/GB2293602B/en not_active Expired - Fee Related
- 1995-09-18 AT AT0154295A patent/AT407988B/de not_active IP Right Cessation
- 1995-09-18 FR FR9510921A patent/FR2724655B1/fr not_active Expired - Fee Related
- 1995-09-18 HU HU9502723A patent/HU227683B1/hu not_active IP Right Cessation
- 1995-09-18 HR HR950483A patent/HRP950483B1/xx not_active IP Right Cessation
- 1995-09-18 HR HR950482A patent/HRP950482B1/xx not_active IP Right Cessation
- 1995-09-18 AT AT0154395A patent/AT502957A1/de not_active Application Discontinuation
- 1995-09-18 MY MYPI95002762A patent/MY116371A/en unknown
- 1995-09-18 BE BE9500760A patent/BE1009625A3/fr active
- 1995-09-18 LU LU88660A patent/LU88660A1/fr unknown
- 1995-09-18 CN CN95118629A patent/CN1075069C/zh not_active Expired - Lifetime
- 1995-09-18 FI FI954403A patent/FI121424B/fi not_active IP Right Cessation
- 1995-09-18 BR BR9504060A patent/BR9504060A/pt not_active IP Right Cessation
- 1995-09-18 JP JP7238211A patent/JP2860071B2/ja not_active Expired - Lifetime
- 1995-09-18 FR FR9510922A patent/FR2732020B1/fr not_active Expired - Fee Related
- 1995-09-18 BR BR9504059A patent/BR9504059A/pt not_active IP Right Cessation
- 1995-09-18 AU AU31731/95A patent/AU692907B2/en not_active Ceased
- 1995-09-18 GR GR950100341A patent/GR1002709B/el not_active IP Right Cessation
- 1995-09-18 LV LVP-95-284A patent/LV11177B/en unknown
- 1995-09-18 CH CH02629/95A patent/CH691125A5/de not_active IP Right Cessation
- 1995-09-18 GB GB9519028A patent/GB2293382B/en not_active Expired - Fee Related
- 1995-09-19 TR TR95/01136A patent/TR199501136A2/xx unknown
- 1995-09-19 EE EE9700055A patent/EE03386B1/xx unknown
- 1995-09-19 RS YU61495A patent/RS49513B/sr unknown
- 1995-09-19 SK SK233-97A patent/SK283502B6/sk not_active IP Right Cessation
- 1995-09-19 DE DE19534744A patent/DE19534744A1/de not_active Ceased
- 1995-09-19 RS YUP-613/95A patent/RS49578B/sr unknown
- 1995-09-19 PL PL95310517A patent/PL187686B1/pl not_active IP Right Cessation
- 1995-09-19 PL PL95310518A patent/PL182450B1/pl not_active IP Right Cessation
- 1995-09-19 AU AU37186/95A patent/AU3718695A/en not_active Abandoned
- 1995-09-19 IE IE950721A patent/IE80883B1/en not_active IP Right Cessation
- 1995-09-19 DE DE19549755A patent/DE19549755B4/de not_active Expired - Fee Related
- 1995-09-19 AP APAP/P/1997/000938A patent/AP754A/en active
- 1995-09-19 IE IE950722A patent/IE950722A1/en not_active IP Right Cessation
- 1995-09-19 DE DE19534745A patent/DE19534745B4/de not_active Expired - Fee Related
- 1995-09-19 GE GEAP19953626A patent/GEP19991821B/en unknown
- 1995-09-19 WO PCT/US1995/011872 patent/WO1996009045A1/en active Application Filing
1997
- 1997-01-09 DK DK199700028A patent/DK175886B1/da not_active IP Right Cessation
- 1997-01-09 DK DK199700027A patent/DK175887B1/da not_active IP Right Cessation
- 1997-02-18 BG BG101242A patent/BG62793B1/bg unknown
- 1997-03-18 IS IS4446A patent/IS1788B/is unknown
- 1997-03-19 OA OA60977A patent/OA10406A/en unknown
1998
- 1998-12-23 HK HK98115201A patent/HK1019009A1/xx not_active IP Right Cessation
2002
- 2002-02-26 US US10/083,179 patent/US20020173645A1/en not_active Abandoned

Also Published As

Publication number	Publication date
GR1002709B (el)	1997-06-04
PE32796A1 (es)	1996-08-07
CH691594A5 (de)	2001-08-31
PL310518A1 (en)	1996-04-01
LV11177B (en)	1996-08-20
IL125283A (en)	2001-06-14
CZ292007B6 (cs)	2003-07-16
JP2860071B2 (ja)	1999-02-24
IE80883B1 (en)	1999-05-19
US6399778B1 (en)	2002-06-04
CN1127253A (zh)	1996-07-24
UA42716C2 (uk)	2001-11-15
NZ280027A (en)	1997-05-26
NO953657D0 (no)	1995-09-15
PT101771B (pt)	1997-04-30
JPH08176147A (ja)	1996-07-09
UA44240C2 (uk)	2002-02-15
HUT74178A (en)	1996-11-28
CN1132205A (zh)	1996-10-02
IE950722A1 (en)	1996-03-20
KR100381346B1 (ko)	2004-04-13
AU692907B2 (en)	1998-06-18
FR2732020B1 (fr)	1997-11-14
DK2797A (da)	1997-01-09
PT101770A (pt)	1996-04-30
YU61495A (sh)	1998-05-15
NO953658L (no)	1996-03-20
FI121424B (fi)	2010-11-15
AT407988B (de)	2001-07-25
CH691125A5 (de)	2001-04-30
NL1001196A1 (nl)	1996-03-19
ES2109882B1 (es)	1998-08-16
BR9504060A (pt)	1996-09-24
RS49578B (sr)	2007-04-10
TW412534B (en)	2000-11-21
NO953658D0 (no)	1995-09-15
ITMI951935A0 (it)	1995-09-15
CZ240395A3 (en)	1996-04-17
CN1075069C (zh)	2001-11-21
DK175903B1 (da)	2005-06-06
ES2129293B1 (es)	2000-01-16
FI954402A (fi)	1996-03-20
NL1001194C2 (nl)	1997-04-04
US20020173645A1 (en)	2002-11-21
UY24040A1 (es)	1996-03-07
ITMI951936A0 (it)	1995-09-15
JPH08193081A (ja)	1996-07-30
AP754A (en)	1999-07-22
DE19534744A1 (de)	1996-03-21
EE03386B1 (et)	2001-04-16
FI954402A0 (fi)	1995-09-18
SE9503214L (sv)	1996-03-20
PL187686B1 (pl)	2004-09-30
HK1019009A1 (en)	2000-01-14
DK175887B1 (da)	2005-05-23
MY116371A (en)	2004-01-31
SI9500293A (en)	1996-06-30
ES2129293A1 (es)	1999-06-01
SE9503213D0 (sv)	1995-09-15
TR199501136A2 (tr)	1996-06-21
NO308107B1 (no)	2000-07-24
SE9503213L (sv)	1996-03-20
IT1277602B1 (it)	1997-11-11
IL115315A0 (en)	1995-12-31
KR100367376B1 (ko)	2003-03-06
PT101770B (pt)	1997-04-30
IS4446A (is)	1997-03-18
NZ280028A (en)	1997-05-26
CA2158400C (en)	2006-10-24
CO4410191A1 (es)	1997-01-09
DK2897A (da)	1997-01-09
ITMI951936A1 (it)	1997-03-15
BE1009626A3 (fr)	1997-06-03
AT502957A1 (de)	2007-06-15
DK102895A (da)	1996-03-20
SE520721C2 (sv)	2003-08-12
BR9504059A (pt)	1996-09-24
GB2293382A (en)	1996-03-27
FR2724655A1 (fr)	1996-03-22
FI954403A (fi)	1996-03-20
NO313996B1 (no)	2003-01-13
SE9503214D0 (sv)	1995-09-15
IS1788B (is)	2001-11-28
PL182450B1 (pl)	2002-01-31
BG101242A (en)	1998-03-31
GB2293382B (en)	1998-08-19
CH691478A5 (de)	2001-07-31
WO1996009045A1 (en)	1996-03-28
GR1002697B (el)	1997-05-22
HUT75033A (en)	1997-03-28
KR960010637A (ko)	1996-04-20
GEP19991821B (en)	1999-11-05
DK175886B1 (da)	2005-05-23
CZ240295A3 (en)	1996-04-17
NO953657L (no)	1996-03-20
EG23763A (en)	2007-08-08
FI954403A0 (fi)	1995-09-18
US6472531B1 (en)	2002-10-29
LV11178B (en)	1996-08-20
LU88660A1 (fr)	1996-07-15
IT1277601B1 (it)	1997-11-11
IL115314A0 (en)	1996-05-14
GB9519028D0 (en)	1995-11-15
SK23397A3 (en)	1997-08-06
HU225417B1 (en)	2006-11-28
IL115315A (en)	1999-09-22
HRP950482A2 (en)	1998-02-28
DE19534745A1 (de)	1996-04-04
HU9502721D0 (en)	1995-11-28
HU9502723D0 (en)	1995-11-28
ITMI951935A1 (it)	1997-03-15
CA2158399A1 (en)	1996-03-20
FR2732020A1 (fr)	1996-09-27
NL1001196C2 (nl)	1997-04-04
FI112226B (fi)	2003-11-14
DK102795A (da)	1996-03-20
GB9519032D0 (en)	1995-11-15
PL310517A1 (en)	1996-04-01
PT101771A (pt)	1996-04-30
SE509265C2 (sv)	1998-12-21
GB2293602B (en)	1998-05-06
CO4410190A1 (es)	1997-01-09
ES2109882A1 (es)	1998-01-16
HRP950483B1 (en)	2003-02-28
RO115260B1 (ro)	1999-12-30
LU88661A1 (fr)	1996-07-15
HRP950482B1 (en)	2007-04-30
FR2724655B1 (fr)	1997-11-14
OA10406A (en)	2001-12-05
HU227683B1 (en)	2011-11-28
GB2293602A (en)	1996-04-03
YU61395A (sh)	1998-09-18
DK175897B1 (da)	2005-05-30
US5731327A (en)	1998-03-24
RS49513B (sr)	2006-10-27
RO115259B1 (ro)	1999-12-30
NL1001194A1 (nl)	1996-03-19
AU3173095A (en)	1996-04-04
DE19534745B4 (de)	2004-06-09
AU3173195A (en)	1996-04-04
CZ290343B6 (cs)	2002-07-17
EE9700055A (et)	1997-08-15
SK283502B6 (sk)	2003-08-05
SI9500292A (en)	1996-06-30
AP9700938A0 (en)	1997-04-30
IL115314A (en)	2000-02-29
IE950721A1 (en)	1996-03-20
BE1009625A3 (fr)	1997-06-03
LV11178A (lv)	1996-04-20
AU691955B2 (en)	1998-05-28
HRP950483A2 (en)	1997-10-31
PE14796A1 (es)	1996-05-19
BG62793B1 (bg)	2000-08-31
CA2158400A1 (en)	1996-03-20
KR960010634A (ko)	1996-04-20
AU3718695A (en)	1996-04-09
CA2158399C (en)	2001-03-20
ATA154295A (de)	2000-12-15
DE19549755B4 (de)	2005-05-04
CN1068324C (zh)	2001-07-11

Publication	Publication Date	Title
LV11177A (lv)	1996-04-20	Jauns farmaceitisks produkts
FI973243A (fi)	1997-08-06	Uusi farmaseuttinen yhdistelmä
FI971279A0 (fi)	1997-03-26	Lääkkeitä
ZA957753B (en)	1997-03-14	Novel pharmaceutical product
BR9610214A (pt)	1999-06-15	Compostos farmacéuticos
DK0813586T3 (da)	2000-02-28	Mugfjernelsesprodukt
BR9508339A (pt)	1997-09-30	Medicamento
ZA95704B (en)	1995-10-25	A pharmaceutical product
ZA95703B (en)	1995-09-29	A pharmaceutical product
NO965448D0 (no)	1996-12-18	Farmasöytiske forbindelser
AU126984S (en)	1996-06-05	Pharmaceutical product
KR950022649U (ko)	1995-08-18	약탕기
MD150B1 (ro)	1995-02-28	Produs curativoprofilactic
UA1090S (uk)	1995-12-26	Фармацевтичний виріб
DK128993D0 (da)	1993-11-15	Laegemiddel/-plante
UA25976C2 (uk)	1999-02-26	Противиразковий лікарський препарат
UA755S (uk)	1995-03-31	Етикетка для лікеро-горілчаного виробу
UA756S (uk)	1995-03-31	Етикетка для лікеро-горілчаного виробу
UA754S (uk)	1995-03-31	Етикетка для лікеро-горілчаного виробу
UA759S (uk)	1995-03-31	Етикетка для лікеро-горілчаного виробу
UA757S (uk)	1995-03-31	Етикетка для лікеро-горілчаного виробу
UA666S (uk)	1994-12-29	Таблетка істивна, зокрема фармацевтична
DK38393D0 (da)	1993-03-31	Nyt laegemiddel
DK137192D0 (da)	1992-11-12	Laegemiddel/-plante
FI942U1 (fi)	1993-10-14	Brandfritt baerande byggnadselement